Biotech

Hera Biotech to Acquire Endometriosis Diagnostic Assets from Scailyte in Move Towards Non-Surgical Diagnosis
Orchid Introduces Whole Genome Sequencing Reports for Embryos After Raising $12M in Funding
MDisrupt Secures $3M in Seed Funding for Its Platform Connecting Companies with Healthcare Experts
Evvy Raises $14M in Series A Funding to Grow and Evolve Its Vaginal Healthcare Platform
InsideTracker Unveils New DNA Insights Focused on Menopausal Age, Bone Density, and More
Notify Therapeutics Secures €5M for the Development of a Non-Hormonal Fertility Treatment
Asieris’ Cevira, the First Non-Vaccine Investigational Product for Cervical HSIL, Has Achieved Its Primary Endpoint
NK:IO Secures £1.2M in Latest Funding Round to Advance Ovarian Cancer Treatment with Cell Therapy
Celmatix and Aché Laboratórios Partner to Develop Melatonin Receptor Agonists for PCOS
Mirvie Receives a $4.6M Grant from the Gates Foundation to Study Preeclampsia in Sub-Saharan Africa
Octave Bioscience Secures $30M for Its Precision Care Solution for Multiple Sclerosis
New Study: Zai Lab’s ZEJULA Maintenance Therapy Shows Promising Results in Advanced Ovarian Cancer Patients
New Study Validates Ziwig’s Saliva-based Endotest as Effective Alternative to Surgical Diagnosis for Endometriosis
Freya Biosciences’ FB101 Shows Promise in Treating Vaginal Dysbiosis
FDA Approves Thermo Fisher’s Immunoassays for Risk Assessment of Preeclampsia
Women-Led Vertex Ventures HC Launches $200M Fund III to Back Life Sciences and Medtech Companies
Vistagen’s PH80 Nasal Spray Shows Promising Results in Menopausal Hot Flash Study
Futura Medical Raises £4.37M After Winning FDA Approval for Its ED Topical Gel
Women’s Health Company Mithra Reports Promising Data for Its CSF-1R Inhibitor in Preclinical Cancer Models
Women-led Mozart Therapeutics Secures $25M for the Clinical Development of Autoimmune Disease Treatments
Gedea Biotech Secures €1.3M to Accelerate the Market Launch of Its Antibiotic-Free Vaginal Infection Treatment
Kallyope Receives $8.3M from the Gates Foundation to Identify Novel Interventions for Undernourished Infants and Pregnant Women
Biotech Company Celmatix Launches Novel PCOS Drug Program Targeting Melatonin Receptors
Consumer Biotech Company Tally Health Raises $10M for Its Platform Aimed at Extending Longevity